Omalizumab for management of hypersensitivity reactions to anticancer drugs

被引：1

作者：

Grover, Piyush ^{[1
,2
,3
]}

Krummenacher, Matthew ^{[1
]}

Loy, Timothy ^{[1
]}

Nowak, Anna K. ^{[2
]}

Lucas, Michaela ^{[1
,2
,4
,5
]}

机构：

[1] Sir Charles Gairdner Hosp, Dept Immunol, Perth, WA, Australia

[2] Univ Western Australia, Med Sch, Perth, WA, Australia

[3] Fiona Stanley Hosp, Dept Med Oncol, Perth, WA, Australia

[4] Perth Childrens Hosp, Dept Immunol, Perth, WA, Australia

[5] PathWest, Perth, WA, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2024年 / 54卷 / 08期

关键词：

allergy; cancer drugs; omalizumab; desensitisation; DESENSITIZATION; IGE; ASTHMA;

D O I：

10.1111/imj.16464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hypersensitivity reactions to anticancer drugs include treatment-limiting toxicity. Standard drug desensitisation offers temporary tolerance and hence requires repetition. We used omalizumab, an anti-immunoglobulin E antibody, to overcome immediate and delayed hypersensitivity reactions to various anticancer drugs. Seven of the eight patients in the current study successfully resumed the desired anticancer drug regimen without standard desensitisation. No safety issues from omalizumab were observed.

引用

页码：1396 / 1400

页数：5

共 21 条

[11]

Li JR, 2020, J CLIN ONCOL, V38

[12] Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria [J].

Maurer, Marcus ;

Rosen, Karin ;

Hsieh, Hsin-Ju ;

Saini, Sarbjit ;

Grattan, Clive ;

Gimenez-Arnau, Ana ;

Agarwal, Sunil ;

Doyle, Ramona ;

Canvin, Janice ;

Kaplan, Allen ;

Casale, Thomas .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (10) :924-935

[13] Readministration of Platinum Agents in Recurrent Ovarian Cancer Patients Who Developed Hypersensitivity Reactions to Carboplatin [J].

Narui, Chikage ;

Tanabe, Hiroshi ;

Shapiro, Jason S. ;

Nagayoshi, Yoko ;

Maruta, Takenori ;

Inoue, Momoko ;

Hirata, Yukihiro ;

Komazaki, Hiromi ;

Takano, Hirokuni ;

Niimi, Shigeki ;

Isonishi, Seiji ;

Okamoto, Aikou .

IN VIVO, 2019, 33 (06) :2045-2050

[14] Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels [J].

Ojaimi, Samar ;

Harnett, Paul R. ;

Fulcher, David A. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (01) :105-106

[15] Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab [J].

Prieto-Garcia, A. ;

Noguerado, B. ;

Rojas, P. ;

Torrado, I ;

Rodriguez-Fernandez, A. ;

Tornero, P. .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (01) :53-55

[16] Cancer statistics, 2023 [J].

Siegel, Rebecca L. ;

Miller, Kimberly D. ;

Wagle, Nikita Sandeep ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2023, 73 (01) :17-48

[17] Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies [J].

Sloane, David ;

Govindarajulu, Usha ;

Harrow-Mortelliti, Jacob ;

Barry, William ;

Hsu, Florence Ida ;

Hong, David ;

Laidlaw, Tanya ;

Palis, Ross ;

Legere, Henry ;

Bunyavanich, Supinda ;

Breslow, Rebecca ;

Wesemann, Duane ;

Barrett, Nora ;

Brennan, Patrick ;

Chong, Hey Jin ;

Liu, Anne ;

Fernandez, James ;

Fanning, Laura ;

Kyin, Timothy ;

Cahill, Katherine ;

Bankova, Lora ;

Lynch, Ashly ;

Berlin, Suzanne ;

Campos, Susana ;

Fuchs, Charles ;

Mayer, Robert ;

Matulonis, Ursula ;

Castells, Mariana .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2016, 4 (03) :497-504

[18] Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [J].

Stupp, R ;

Mason, WP ;

van den Bent, MJ ;

Weller, M ;

Fisher, B ;

Taphoorn, MJB ;

Belanger, K ;

Brandes, AA ;

Marosi, C ;

Bogdahn, U ;

Curschmann, J ;

Janzer, RC ;

Ludwin, SK ;

Gorlia, T ;

Allgeier, A ;

Lacombe, D ;

Cairncross, JG ;

Eisenhauer, E ;

Mirimanoff, RO ;

Van Den Weyngaert, D ;

Kaendler, S ;

Krauseneck, P ;

Vinolas, N ;

Villa, S ;

Wurm, RE ;

Maillot, MHB ;

Spagnolli, F ;

Kantor, G ;

Malhaire, JP ;

Renard, L ;

De Witte, O ;

Scandolaro, L ;

Vecht, CJ ;

Maingon, P ;

Lutterbach, J ;

Kobierska, A ;

Bolla, M ;

Souchon, R ;

Mitine, C ;

Tzuk-Shina, T ;

Kuten, A ;

Haferkamp, G ;

de Greve, J ;

Priou, F ;

Menten, J ;

Rutten, I ;

Clavere, P ;

Malmstrom, A ;

Jancar, B ;

Newlands, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (10) :987-996

[19] Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations [J].

Teach, Stephen J. ;

Gill, Michelle A. ;

Togias, Alkis ;

Sorkness, Christine A. ;

Arbes, Samuel J., Jr. ;

Calatroni, Agustin ;

Wildfire, Jeremy J. ;

Gergen, Peter J. ;

Cohen, Robyn T. ;

Pongracic, Jacqueline A. ;

Kercsmar, Carolyn M. ;

Hershey, Gurjit K. Khurana ;

Gruchalla, Rebecca S. ;

Liu, Andrew H. ;

Zoratti, Edward M. ;

Kattan, Meyer ;

Grindle, Kristine A. ;

Gern, James E. ;

Busse, William W. ;

Szefler, Stanley J. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (06) :1476-1485

[20]

Vogel Wendy H, 2010, Clin J Oncol Nurs, V14, pE10, DOI 10.1188/10.CJON.E10-E21

← 1 2 3 →